Nicorandil extended release - Auxilius Pharma
Alternative Names: AUX-001Latest Information Update: 10 Feb 2025
At a glance
- Originator Auxilius Pharma
- Class Ischaemic heart disorder therapies; Nitrates; Small molecules; Vasodilators
- Mechanism of Action Guanylate cyclase stimulants; KATP channel stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Angina pectoris
Most Recent Events
- 04 Feb 2025 Auxilius Pharma announces intention to submit IND to US FDA for Angina pectoris
- 16 Nov 2024 Updated adverse events data from a phase I trial in Angina pectoris presented at the American Heart Association Scientific Sessions 2024 (AHA-2024)
- 30 Aug 2024 Updated adverse events and pharmacokinetics data from the phase I trial in Angina pectoris presented at the ESC Congress 2024 - Annual Congress of the European Society of Cardiology (ESC-Card-2024)